<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045384"><TermName>carboxypeptidase-G2</TermName><TermPronunciation>(kar-BOK-see-PEP-tih-days …)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat toxic levels of methotrexate (an anticancer drug) in the blood of patients with kidney problems. It is a bacterial enzyme that breaks down proteins and other substances, such as methotrexate. Carboxypeptidase-G2 may also help certain drugs kill cancer cells. It is a type of chemoprotective agent and a type of prodrug activator. Also called glucarpidase and Voraxaze.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705399" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;carboxypeptidase-G2&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705398" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;carboxypeptidasa-G2&quot;" language="es" id="_4"/><SpanishTermName>carboxypeptidasa-G2</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar concentraciones tóxicas de metotrexato (un medicamento contra el cáncer) en la sangre de pacientes con problemas renales. Es una enzima bacteriana que descompone proteínas y otras sustancias, como el metotrexato. La carboxypeptidasa-G2 también puede ayudar a que ciertos medicamentos destruyan células cancerosas.   Es un tipo de quimioprotector y un tipo de activador de profármacos.  También se llama glucarpidasa y Voraxaze.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2012-02-23</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000723873">Glucarpidase</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
